Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Columbia Labs Buys Molecular Profiles
by Ann M. Thayer
September 23, 2013
| A version of this story appeared in
Volume 91, Issue 38
Boston’s Columbia Laboratories has acquired Molecular Profiles, a Nottingham, England-based drug development services company. Columbia will pay $16.7 million in cash and another $8.3 million in stock. Molecular Profiles had revenues of about $9 million for the fiscal year ending July 31. Over the past four years, its revenues have been growing about 15% annually. The acquisition will expand Columbia’s business, now focused on R&D for women’s health care and drug delivery, into formulation development and manufacturing for the pharmaceutical outsourcing market.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X